RT @bella_mehta: Year in review #ACR22 IVIG received FDA approval for dermatomyositis in 2022! @RheumNow
Tweet Content
Year in review #ACR22
IVIG received FDA approval for dermatomyositis in 2022!
@RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off